Progress in the prevention and treatment of peritoneal dialysis-associated fungal peritonitis

doi:10.3877/cma.j.issn.2095-3216.2020.06.004

Abstract

Abstract:

Peritoneal dialysis-associated peritonitis (PDAP) is the main reason that causes patients to withdraw from peritoneal dialysis. Although fungal peritonitis (FP) accounted for less in PDAP, it had the lowest cure rate, the highest technical failure rate and PDAP-related mortality. However, there is still no unified FP prevention and treatment program. The drugs to prevent FP mainly include nystatin and fluconazole, but the timing of their use has not been determined. Treatment of FP mainly includes catheter removal and antifungal therapy. However, although catheter removal is required in most cases, the optimal time for catheter removal is still unknown. In this paper, the prevention and treatment of peritoneal dialysis-related FP was reviewed in combination with recent important clinical studies.

Key words: Fungal peritonitis, Peritoneal dialysis, Prevention, Treatment

Xinyang Li, Yu Zhang, Peiting Luo, Yangwei Wang, Wenpeng Cui. Progress in the prevention and treatment of peritoneal dialysis-associated fungal peritonitis[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2020, 09(06): 260-263.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2020.06.004

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2020/V09/I06/260

References 26

[1]	Bargman JM, Fredette N, Claire A. Characteristics and outcomes of fungal peritonitis in a modern north American cohort [J]. Perit Dial Int, 2015, 35(1): 78-84.
[2]	Chavada R, Kok J, Hal SV, et al. Seeking clarity within cloudy effluents: differentiating fungal from bacterial peritonitis in peritoneal dialysis patients [J]. PLoS One, 2011, 6(12): e28247.
[3]	Jayanthi GS, Kumar KV, Mallkarjuna HM. Fungal peritonitis in continuous ambulatory peritoneal dialysis: the impact of antifungal prophylaxis on patient and technique outcomes [J]. Indian J Nephrol, 2014, 24(5): 297-301.
[4]	Hu S, Tong R, Bo Y, et al. Fungal peritonitis in peritoneal dialysis: 5-year review from a North China center [J]. Infection, 2019, 47(1): 35-43.
[5]	Verma A, Mothu PN, Kalawat U, et al. Fungal peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients [J]. J Clin Diagn Res, 2018, 12(8): 6-9.
[6]	Auricchio S, Giovenzana ME, Pozzi M, et al. Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation [J]. Clin Kidney J, 2018, 11(6): 874-880.
[7]	中国腹膜透析相关感染防治专家组. 腹膜透析相关感染的防治指南 [J]. 中华肾脏病杂志，2018, 34(2): 139-148.
[8]	Fan SL, Nicfhogartaigh C. Response to letter "Gram stain of peritoneal dialysis fluid: the potential of direct policy-determining importance in early diagnosis of fungal peritonitis" [J]. Perit Dial Int, 2019, 39(6): 575.
[9]	Chamroensakchai T, Manuprasert W, Puapatanakul P, et al. Serum galactomannan index for the rapid diagnosis of fungal peritonitis in patients with peritoneal dialysis [J]. Kidney Int Rep, 2019, 5(4): 530-534.
[10]	Giacobino J, Montelli AC, Barretti P, et al. Fungal peritonitis in patients undergoing peritoneal dialysis (PD) in Brazil: molecular identification, biofilm production and antifungal susceptibility of the agents [J]. J Med Vet Myco, 2016, 54(7): 725-732.
[11]	García AR, García MP. Aspectos clínicos y microbiológicos de la peritonitis fúngica en diálisis peritoneal [J]. Nefrología, 2009, 29(29): 506-517.
[12]	Szeto CC, Li PKT. Peritoneal dialysis-associated peritonitis [J]. Clin J Am Soc Nephrol, 2019, 14(7): 1100-1105.
[13]	Wong PN, Lo KY, Tong GMW, et al. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD [J]. Perit Dial Int, 2007, 27(5): 531-536.
[14]	Restrepo C, Chacon J, Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial [J]. Perit Dial Int, 2010, 30(6): 619-625.
[15]	Lopes K, Rocha A, Rodrigues A, et al. Long-term peritoneal dialysis experience: quality control supports the use of fluconazole to prevent fungal peritonitis [J]. Int J Artif Organs, 2013, 36(7): 484-488.
[16]	Prabhu MV, Subhramanyam SV, Gandhe S, et al. Prophylaxis against fungal peritonitis in CAPD-a single center experience with low-dose fluconazole [J]. Ren Fail, 2010, 32(7): 802-805.
[17]	Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment [J]. Perit Dial Int, 2016, 36(5): 481-508.
[18]	Wong P, Lo K, Tong G, et al. Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine, and delayed catheter replacement in continuous ambulatory peritoneal dialysis [J]. Perit Dial Int, 2008, 28(2): 155-162.
[19]	Pappas PG, Kauffman CA, Anders DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America [J]. Clin Infect Dis, 2016, 62: 1-50.
[20]	Ghebremedhin B, Bluemel A, Neumann KH, et al. Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis successfully treated with voriconazole [J]. J Med Microbiol, 2009, 58(Pt 5): 678-682.
[21]	Prépost E, Tóth Z, Perlin DS, et al. Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis [J]. Infect Drug Resist, 2019, 12: 1805-1814.
[22]	Grimaldi D, Daugas E, Mougenot B, et al. Immuno-allergic interstitial nephritis related to fluindione: first biopsy proven cases [J]. Nephrol Dial Transplant, 2006, 21(1): 237.
[23]	Pasqualotto AC, Howard SJ, Moore CB, et al. Flucytosine therapeutic monitoring: 15 years experience from the UK [J]. J Antimicrob Chemother, 2007, 59(4): 791-793.
[24]	Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications [J]. Antimicrob Agents Chemother, 2009, 53(1): 24-34.
[25]	Liu YL, Huang CC, Kao MT. Residual renal function predicts outcome of fungal peritonitis in peritoneal dialysis patients [J]. Perit Dial Int, 2006, 26(3): 407-409.
[26]	Chang TI, Kim HW, Park JT, et al. Early catheter removal improves patient survival in peritoneal dialysis patients with fungal peritonitis: results of ninety-four episodes of fungal peritonitis at a single center [J]. Perit Dial Int, 2011, 31(1): 60-66.

Please choose a citation manager

Content to export